Zepbound vs. Ozempic: Which is best for weight loss?

+1 more
Author picture
Edited by: Joanna Broder
person standing on a weighing scale

Recently, new pharmaceutical innovations have reshaped the weight loss treatment landscape. Among these, the prescription drugs Zepbound and Ozempic have risen in popularity. Both are used to manage obesity and related conditions. Zepbound and Ozempic have gained attention for their effectiveness in weight management.

While both drugs work similarly, they do carry different mechanisms of action. Both Zepbound and Ozempic work as glucagon-like-peptide-1 (GLP-1) receptor agonists. Additionally, Zepbound has a dual approach as a glucose-dependent insulinotropic polypeptide (GIP) hormone receptor. This means there is some overlap between functioning mechanisms.

We’ll break down the differences between each medication, compare their costs and side effects, and look at medical professionals’ opinions on Zepbound and Ozempic.

Differences between Zepbound and Ozempic

Understanding how Zepbound and Ozempic work to promote weight loss involves looking at the action mechanism and biological processes they influence. Both drugs offer effective solutions but operate through distinct and overlapping pathways. Both target various aspects of hunger, metabolism and blood sugar control.

Zepbound

Zepbound’s active ingredient, tirzepatide, uses a combination of two different drug classes for its weight loss effects. Here’s more about Zepbound:

  • How it works: Zepbound is a medication that was developed specifically for obesity management and weight loss. It combines two drug types (GLP-1 and GIP) that target physiological pathways involved in hunger and metabolism. The active ingredient in Zepbound, tirzepatide, operates by activating hormone receptors from the intestines to reduce appetite and food intake.
  • Appetite regulation: Zepbound actives GLP-1 hormone receptors to reduce appetite and food intake.
  • Metabolic effects: Zepbound affects insulin sensitivity and glucose metabolism, which provides a more efficient use of stored energy and reduces fat accumulation.
  • Who Zepbound is approved for: Zepbound is approved for weight loss in adults who meet certain body mass index (BMI) criteria.

Ozempic

Ozempic’s active ingredient is semaglutide, which is a GLP-1 receptor agonist. Here are more details on Ozempic:

  • How it works: Ozempic is a medication that was originally developed to treat Type 2 diabetes. Its active ingredient, semaglutide, has shown results in promoting weight loss, which led to its use as a weight-management solution. Ozempic’s weight loss effect comes from its role as a GLP-1 receptor agonist. GLP-1 is a hormone that helps regulate blood sugar levels and appetite. Ozempic helps slow gastric emptying, reduce appetite and improve insulin sensitivity.
  • Appetite reduction: Ozempic mimics the action of GLP-1, a hormone that helps regulate appetite. By activating the GLP-1 receptors, Ozempic slows gastric emptying, which prolongs feeling full and reduces overall food intake.
  • Blood sugar control: Ozempic improves insulin sensitivity and lowers blood sugar levels. It enhances the body’s ability to use insulin effectively. This helps stabilize blood glucose and lower insulin resistance risk. The dual effect of appetite and glucose control contributes to weight loss.
  • Who Ozempic is approved for: Ozempic is approved for Type 2 diabetes in adults. It can also lower the risk of serious cardiovascular problems in people with both Type 2 diabetes and heart disease.

The choice between the two medications depends on Food and Drug Administration (FDA) approval indications and individual needs, including specific health profiles and treatment goals.

Effectiveness of Zepbound vs. Ozempic

Zepbound and Ozempic are both used to aid in weight loss, but they belong to different classes and have different mechanisms of action.

  • Zepbound: It is relatively new and was tested in multiple clinical trials to assess weight loss efficacy. Trials showed Zepbound led to a significant reduction in body weight.
  • Ozempic: Ozempic is an established medication that is primarily used for managing Type 2 diabetes. However, Ozempic has also been shown to be effective for weight loss. Clinical trials showed that Ozempic led to an average weight loss of 5.9% at three months and 10.9% at six months.

Zepbound and Ozempic are both typically administered via injections. Rybelsus is semaglutide (Ozempic) in pill form. If there’s an available tirzepatide (Zepbound) pill form in the future, there could potentially be greater convenience and adherence compared with injections.

Zepbound vs. Ozempic cost comparison

Zepbound and Ozempic have different price points. As a newer medication, Zepbound tends to be more expensive than Ozempic.

  • Zepbound’s current list price is $1,059.87 per month. Lilly recently began offering Zepbound for $399 to $549 per month directly to consumers.
  • Ozempic averages around $900 to $1,000 for a one-month supply.

It’s important to note that these prices are without insurance coverage. Some major insurance plans may provide some sort of coverage for Zepbound and/or Ozempic. Consult your health insurance plan for more details.

Additionally, some pharmacies currently are providing a compounded version of the injections with the respective active ingredients at a lower cost. This provides a more cost-effective solution in some cases.

However, it should be noted that compounded drugs are not formally approved by the FDA. “Compounded drugs pose a higher risk to patients than FDA-approved drugs because compounded drugs do not undergo FDA premarket review for safety, quality or effectiveness,” according to the FDA.

Additionally, compounding pharmacies may only produce certain medications if there is a specific personalized need in an individual patient (e.g., if a patient has difficulty tolerating an FDA-approved medicine due to the formulation) or if the FDA declares a drug shortage on a particular drug.

A spokesperson from the FDA recently told ConsumerAffairs in an email that it is working to decide if the current supply of semaglutide meets the FDA’s definition of a resolved shortage.

Health care professional opinions on Zepbound vs. Ozempic

Health care professionals offer a range of insights on Zepbound and Ozempic for weight loss.

Professional opinions on Zepbound

With Zepbound being a newer medication, it’s under close watch by the medical community. Experts have noted it has promising efficacy in clinical trials, with significant weight loss results.

Professional opinions on Ozempic

Ozempic is an established medication with a well-documented history of effectiveness and safety. Experts see its dual role in managing Type 2 diabetes and helping in weight loss. The FDA has also approved Ozempic for reducing the risk of major heart events in people with Type 2 diabetes and known heart disease. It has a solid safety profile, but Ozempic does have common side effects, which include gastrointestinal issues like nausea, diarrhea and constipation.

Professional opinions on switching between Zepbound and Ozempic

Because Zepbound and Ozempic work differently, you may want to switch between the two drugs to achieve the desired results. However, currently there is not a lot known about how well it works to switch from one to the other.

Health care professionals may recommend a change based on effectiveness, side effects or changes in a patient’s health. When you’re switching, it’s essential to carefully manage the transition to avoid treatment gaps or potential medication interactions. Additionally, a health care provider will guide you through switching so it’s done safely.

Experts highly emphasize the need for close medical supervision for both Zepbound and Ozempic. Additionally, experts recommend pairing the medication with healthier lifestyle habits to achieve lasting weight loss results.

Zepbound vs. Ozempic side effects and safety

Zepbound and Ozempic both have common side effects.

Zepbound

  • Gastrointestinal issues: Nausea, vomiting and diarrhea
  • Abdominal pain: Discomfort or pain in the abdominal area
  • Fatigue: Noticeable decrease in energy levels
  • Appetite changes: Increase or decrease in appetite levels

Zepbound has some rare but severe side effects, including hypoglycemia, acute pancreatitis and cholecystitis (inflammation of the gallbladder) and possibly thyroid tumors.

Ozempic

  • Gastrointestinal issues: nausea, vomiting and diarrhea
  • Abdominal pain: abdominal pain or discomfort
  • Loss of appetite: Reduced appetite

Ozempic’s rare yet severe side effects include pancreatitis, kidney damage, possible thyroid tumors and gallbladder disease.

In addition to side effects, it’s important to consider Zepbound’s and Ozempic’s safety profiles. Both have positive safety profiles. With Zepbound being a newer medication, comprehensive long-term data is still being collected. However, initial studies show promising safety information. Ozempic is more established and has a longer use history. Its safety profile is well documented.

The best way for you to manage risks and side effects is to consult health care providers before starting the medication and throughout use. Start slowly to help mitigate side effects and be mindful of symptoms. By adhering to the prescribed dosage, you can minimize side effects and enhance medication effectiveness.

FAQ

Is Ozempic more expensive than Zepbound?

No, Ozempic isn’t more expensive than Zepbound. Zepbound’s average cost is higher than Ozempic’s. The caveat to this is that, recently, the maker of Zepbound, Eli Lilly, began offering a program through its LillyDirect online pharmacy where consumers can directly purchase 2.5-mg or 5-mg doses for $399 and $549 per month.

Can I use Zepbound and Ozempic together for better results?

No, you can’t use Zepbound and Ozempic at the same time.

Can I switch from Zepbound to Ozempic for weight loss?

Yes, you can switch from Zepbound to Ozempic. This should be done under guidance from your health care provider.

Which weight loss medication is more effective, Zepbound or Ozempic?

Both Ozempic and Zepbound have high efficacy ratings. A health care provider can help you determine which weight loss medication is right for you based on your individual health profile.

Bottom line

Zepbound and Ozempic are two prominent weight-loss injection options. Consult with a health care professional before starting either medication.

Zepbound is newer to the weight loss community and has gained attention for its weight loss effectiveness. Clinical trials have demonstrated significant weight loss in participants, sometimes exceeding 15% of body weight. Zepbound was developed specifically for weight loss for those who are obese and have struggled with previous weight loss methods.

Ozempic has historically been used to treat Type 2 diabetes. It has recently shown promising weight loss results. The average weight reduction with Ozempic is lower than Zepbound, but it is still considered effective.

For significant weight loss, Zepbound may be the better option. If you have Type 2 diabetes and are looking for a dual approach to managing weight and the disease, Ozempic would likely be more suitable. Ultimately, talk to your doctor about health needs, financial situation and personal weight loss goals.


Article sources
ConsumerAffairs writers primarily rely on government data, industry experts and original research from other reputable publications to inform their work. Specific sources for this article include:
  1. Food and Drug Administration, “Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss.” Accessed Sept. 19, 2024.
  2. Food and Drug Administration, “OZEMPIC (semaglutide) injection, for subcutaneous use.” Accessed Sept. 19, 2024.
  3. Food and Drug Administration, “FDA Approves New Medication for Chronic Weight Management.” Accessed Sept. 19, 2024.
  4. Food and Drug Administration, “ZEPBOUND (tirzepatide) Injection, for subcutaneous use.” Accessed Sept. 19, 2024.
  5. Lilly, “How much should I expect to pay for Zepbound?” Accessed Sept. 19, 2024.
Did you find this article helpful? |
Share this article